| Titolo | Fase | Stato | Sede patologia | Strutture coinvolte | Dettaglio |
TROPION-Breast05 A Phase III, Open-label, Randomised Study of Datopotamab Deruxtecan (Dato-DXd) With or Without Durvalumab Compared with Investigator’s Choice of Chemotherapy (Paclitaxel, Nab-paclitaxel or Gemcitabine + Carboplatin) in Combination With Pembrolizumab in Patients with PD-L1 Positive Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer |
III |
in corso |
CARCINOMA MAMMARIO |
- SC Oncologia Clinica Sperimentale di Senologia |
|
AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 2 STUDY OF THE ATR INHIBITOR TUVUSERTIB IN COMBINATION WITH THE PARP INHIBITOR NIRAPARIB OR THE ATM INHIBITOR LARTESERTIB IN PARTICIPANTS WITH BRCA MUTANT AND/OR OMOLOGOUS RECOMBINATION DEFICIENCY HRD)‑POSITIVE EPITHELIAL OVARIAN CANCER THAT PROGRESSED ON PRIOR PARP INHIBITOR THERAPY |
II |
in corso |
CANCRO OVARICO |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
STUDIO DI REAL-EVIDENCE SU PAZIENTI AFFETTI DA CARCINOMA DEL COLON-RETTO METASTATICO (MCRC) CON MUTAZIONE BRAFV600E IN ITALIA: UNO STUDIO PROSPETTICO NON INTERVENTISTICO |
NA |
in corso |
Cancro del colon-retto |
- SC Oncologia Clinica Sperimentale Addominale |
|
A PHASE 3 RANDOMIZED, ACTIVE-CONTROLLED, OPEN-LABEL, MULTICENTER STUDY TO COMPARE THE EFFICACY AND SAFETY OF MK-2870 MONOTHERAPY VERSUS TREATMENT OF PHYSICIAN’S CHOICE AS SECOND-LINE TREATMENT FOR PARTICIPANTS WITH RECURRENT OR METASTATIC CERVICAL CANCER (TROFUSE-020/GOG-3101/ENGOT-CX20) |
III |
in corso |
CANCRO CERVICE |
- SC Oncologia Clinica Sperimentale Uro - Ginecologica |
|
STUDIO NON INTERVENTISTICO, RETRO-PROSPETTICO, MULTICENTRICO A SINGOLO BRACCIO, DI VALUTAZIONE DELL’EFFICACIA E SICUREZZA DI MOSUNETUZUMAB IN PAZIENTI CON LINFOMA FOLLICOLARE PRECEDENTEMENTE TRATTATI CON ALMENO DUE LINEE DI TERAPIA SISTEMICA |
NA |
in corso |
linfoma follicolare |
SC Ematologia Oncologica - |
